LLLeslie Zhi Wei Lew

Leslie Zhi Wei Lew

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leslie Zhi Wei Lew has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Adrian D Elliott

    The University of Adelaide , Adelaide , Australia

    1 shared publication
  • Anand Thiyagarajah

    Royal Adelaide Hospital , Adelaide , Australia

    1 shared publication
  • Benjamin M. Mac Curtain

    Department of Urology University Hospital Waterford Waterford Ireland

    1 shared publication
  • Bernhard T Baune

    Department of Psychiatry, University of Melbourne , Melbourne , Australia

    1 shared publication
  • Dennis H. Lau

    Australian Dysautonomia and Arrhythmia Research Collaborative, The University of Adelaide, Adelaide, SA, Australia; South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Department of Cardiology, Royal Adelaide Hospital, Adelaide, SA, Australia

    1 shared publication
  • Dian A Munawar

    The University of Adelaide , Adelaide , Australia

    1 shared publication

Latest Publications

  • Predictive Role of FDG PET‐CT in Localised Rectal Carcinoma: A Systematic Review and Meta‐Analysis

    by Leslie Zhi Wei Lew, Benjamin M. Mac Curtain, Teck Siew, Zi Qin Ng

    Introduction: Rectal carcinoma (RC) has high incidence and rate of recurrence. Currently, routine 18‐ fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET‐CT) is not recommend for routine monitoring for post RC treatment. We examined the utility of FDG PET‐CT for the prognostication of patients with RC and what FDG PET‐CT metrics are of value.Methods: PubMed, Embase, MEDLINE, and Cochrane (Central) were comprehensively searched till 19 May 2024. A modified Newcastle Ottawa scale was used to assess for study bias. We presented our systematic review alongside pooled hazard ratios (HR) for maximum standardised uptake values (SUV) as a predictor of disease‐free survival (DFS) and overall survival (OS).Results: Eleven papers including 771 patients were included in our systematic review. Considering the current evidence, there is potential to consider percentage change in SUVmax, TLG, MTV, and lymph node highest peak SUV as possible predictors of outcome for localised non metastatic rectal carcinoma.Conclusions: Pooled meta‐analysis of three homogenous parameters examines the relationship of SUVMax and survival, and did not demonstrate correlation with survival outcomes. The overall pooled hazard ratio for pretreatment SUVMax to DFS was 0.69, CI (0.29–1.63). The overall pooled HR for post treatment SUVMax to DFS was 0.88, CI (0.43–1.81), and posttreatment SUVMax to OS was 1.73, CI (0.34–8.66). Post treatment FDG PET‐CT may have a role to play in the prognostic evaluation of RC patients; however, further data is required.

  • Isolated superior mesenteric artery dissection as a cause of abdominal pain

    by Leslie Zhi Wei Lew, Zi Qin Ng, Sze Ling Wong

  • Diagnosing the acute abdomen during a global contrast shortage: a single centre experience

    by Katie Wang, Mitchell Atkinson, Munyaradzi G. Nyandoro, Kirsten Biddle, Leslie Zhi Wei Lew, Dieter G. Weber

    Background: The COVID‐19 pandemic led to a global shortage of iodinated contrast media (ICM) in early 2022. ICM is used in more than half of the computed tomography of the abdomen and pelvis (CTAP) performed to diagnose an acute abdomen (AA). In response to the shortage, the RANZCR published contrast‐conserving recommendations. This study aimed to compare AA diagnostic outcomes of non‐contrast CTs performed before and during the shortage.Methods: A single‐centre retrospective observational cohort study of all adult patients presenting with an AA who underwent a CTAP was conducted during the contrast shortage period from May to July 2022. The pre‐shortage control comparison group was from January to March 2022; key demographics, imaging modality indication and diagnostic outcomes were collected and analysed using SPSS v27.Results: Nine hundred and sixty‐two cases met the inclusion criteria, of which n = 502, 52.2% were in the shortage period group. There was a significant increase of 464% in the number of non‐contrast CTAPs performed during the shortage period (P < 0.001). For the six AA pathologies, only n = 3, 1.8% of non‐contrast CTAPs had equivocal findings requiring further imaging with a contrast CTAP. Of the total CTs performed, n = 464, 48.2% were negative.Conclusion: This study showed that when non‐contrast CTs are selected appropriately, they appear to be non‐inferior to contrast‐enhanced CTAPs in diagnosing acute appendicitis, colitis, diverticulitis, hernia, collection, and obstruction. This study highlights the need for further research into utilizing non‐contrast scans for assessing the AA to minimize contrast‐associated complications.


  • Top Cited Papers
    Open Access

    Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals

    by Yu Han Koh, Leslie Z W Lew, Kyle B Franke, Adrian D Elliott, Dennis H Lau, Anand Thiyagarajah, Dominik Linz, Margaret Arstall, Phillip J Tully, Bernhard T Baune, et al.

    To systematic review and meta-analyse the association and mechanistic links between atrial fibrillation (AF) and cognitive impairment. PubMed, EMBASE, and Cochrane Library were searched up to 27 March 2021 and yielded 4534 citations. After exclusions, 61 were analysed; 15 and 6 studies reported on the association of AF and cognitive impairment in the general population and post-stroke cohorts, respectively. Thirty-six studies reported on the neuro-pathological changes in patients with AF; of those, 13 reported on silent cerebral infarction (SCI) and 11 reported on cerebral microbleeds (CMB). Atrial fibrillation was associated with 39% increased risk of cognitive impairment in the general population [n = 15: 2 822 974 patients; hazard ratio = 1.39; 95% confidence interval (CI) 1.25–1.53, I2 = 90.3%; follow-up 3.8–25 years]. In the post-stroke cohort, AF was associated with a 2.70-fold increased risk of cognitive impairment [adjusted odds ratio (OR) 2.70; 95% CI 1.66–3.74, I2 = 0.0%; follow-up 0.25–3.78 years]. Atrial fibrillation was associated with cerebral small vessel disease, such as white matter hyperintensities and CMB (n = 8: 3698 patients; OR = 1.38; 95% CI 1.11–1.73, I2 = 0.0%), SCI (n = 13: 6188 patients; OR = 2.11; 95% CI 1.58–2.64, I2 = 0%), and decreased cerebral perfusion and cerebral volume even in the absence of clinical stroke. Atrial fibrillation is associated with increased risk of cognitive impairment. The association with cerebral small vessel disease and cerebral atrophy secondary to cardioembolism and cerebral hypoperfusion may suggest a plausible link in the absence of clinical stroke. PROSPERO CRD42018109185.


  • Sigmoid colon arteriovenous malformation causing spontaneous haemoperitoneum: a case report

    by Leslie Zhi Wei Lew, Ryan Cohen, Yuki Watanabe